An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...

These medications typically help you control your appetite or help your body respond to the foods you eat. However, these ...

more people are turning to old-school weight loss drugs such as Qsymia and Contrave, which come in pill form but also include ...

The weight-loss drug Contrave carries a black box warning about suicidal thinking, and another obesity medicine, Qsymia, carries a warning telling patients to stop taking it if they experience ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

Usnic acid is an antibacterial substance made from lichens. But online marketers sell it as a weight-loss drug and performance enhancer. Since it falls under the FDA category of a dietary ...

It outperformed Orexigen's Mysimba/Contrave weight loss drug, where around a quarter of patients in a phase 3 trial achieved the target. Semaglutide came out top of the analysis, with 63% of ...

Ozempic maker Novo Nordisk’s highly anticipated new obesity pill, Amycretin, shows the potential for much greater and faster ...

The U.S. Food and Drug Administration (FDA ... stop the medication and help you choose a different weight loss treatment. Contrave is a twice-daily medication approved only for adults meeting ...